首页> 外国专利> PROCESS FOR THE PREPARATION OF UNSYMMETRICAL 4,6-BIS (ARYLOXY) PYRIMIDINE COMPOUNDS AND NOVEL INTERMEDIATES THEREOF

PROCESS FOR THE PREPARATION OF UNSYMMETRICAL 4,6-BIS (ARYLOXY) PYRIMIDINE COMPOUNDS AND NOVEL INTERMEDIATES THEREOF

机译:非对称4,6-双(芳基)嘧啶化合物的制备及其新型中间体

摘要

Process for the preparation of an unsymmetrical 4,6-bis (aryloxy) pyrimidine compound of the formula wherein R and R8 are each independently hydrogen or halogen; R1 and R7 are each independently hydrogen, halogen, cyano, nitro, alkyl, haloalkyl, alkoxy, alkylthio, amino, alkylamino, dialkylamino, alkoxyalkyl, haloalkoxyalkyl or alkoxycarbonyl; R2 and R6 are each independently hydrogen, halogen, alkyl, haloalkyl, haloalkoxy, haloalkylthio, haloalkenyl, haloalkynyl, haloalkoxyalkyl, alkoxycarbonyl, haloalkoxycarbonyl, haloalkylsulfinyl, haloalkylsulfonyl, nitro or cyano; R3 and R5 are each independently hydrogen, halogen, alkyl or alkoxy; and R4 is hydrogen, cyano, alkyl, haloalkyl, alkoxy, alkylthio, alkylsulfinyl or phenyl; provided that at least one of R2 and R6 is other than hydrogen, and that the aryloxy groups are not the same; which comprises reacting a 4,6-dihalopyrimidine compound of the formula 892 ל' באב התש" ס - August 31, 2000 wherein R4 is as described above and X is Cl, Br or I with one molar equivalent or less of a first phenol compound of the formula and a first base in the presence of a first solvent to form a 4-halo-6- (aryloxy) pyrimidine compound of the formula reacting the 4-halo-6- (aryloxy) pyrimidine compound with at least about one molar equivalent of a C1-C4 trialkylamine, a 5- to 6-membered saturated or 5- to 14-membered unsaturated heterocyclic amine optionally substituted with one to three C1-C4 alkyl groups or C1-C4 alkoxy groups in the presence of a second solvent to form an ammonium halide compound of the formula 893 ל' באב התש" ס - August 31, 2000 wherein Q+ is R9, R10 and R11 are each independently C1-C4 alkyl, and when taken together, R9 and R10 may form a 5- or 6-membered ring in which R9R10 is represented by the stucture: -(CH2)n-, optionally interrupted by O, S or NR14, where n is an integer of 3, 4 or 5, provided R11 is C1-C4 alkyl; Z is O, S or NR14, R12 and R13 are each independently hydrogen, C1-C4 alkyl or C1-C4 alkoxy, and when taken together, R12 and R13 may form a 5- or 6-membered staturated or unsaturated ring optionally interrupted by O, S or NR14 and optionally substituted with one to three C1-C4 alkyl groups or C1-C4 alkoxy groups; and R14 is C1-C4 alkyl; and reacting the ammonium halide compound with at least about one molar equivalent of a second phenol compound of the formula 894 ל' באב התש" ס - August 31, 2000 Claimed as novel are the intermediates of the formula V.
机译:具有下式的不对称4,6-双(芳氧基)嘧啶化合物的制备方法其中R和R8各自独立地为氢或卤素; R1和R7各自独立地是氢,卤素,氰基,硝基,烷基,卤代烷基,烷氧基,烷硫基,氨基,烷基氨基,二烷基氨基,烷氧基烷基,卤代烷氧基烷基或烷氧基羰基; R2和R6各自独立地是氢,卤素,烷基,卤代烷基,卤代烷氧基,卤代烷硫基,卤代烯基,卤代炔基,卤代烷氧基烷基,烷氧基羰基,卤代烷氧基羰基,卤代烷基亚磺酰基,卤代烷基磺酰基,硝基或氰基; R3和R5各自独立地为氢,卤素,烷基或烷氧基; R4为氢,氰基,烷基,卤代烷基,烷氧基,烷硫基,烷基亚磺酰基或苯基;条件是R2和R6中至少一个不是氢,并且芳氧基不相同;包括使式892的4,6-二卤代嘧啶化合物与2000年8月31日反应,其中R 4如上所述,X为Cl,Br或I与一个摩尔当量或更少的第一酚化合物反应在第一溶剂的存在下,使式(4)的卤代化合物与第一碱反应,以形成使式4-卤代的6-(芳氧基)嘧啶化合物与至少约一个摩尔反应的式的4-卤代6-(芳氧基)嘧啶化合物当量C1-C4三烷基胺,在另一种溶剂存在下任选被1-3个C1-C4烷基或C1-C4烷氧基取代的5至6元饱和或5至14元不饱和杂环胺形成式893的卤化铵化合物-2000年8月31日,其中Q +为R9,R10和R11各自独立地为C1-C4烷基,并且在一起时,R9和R10可以形成5-或6元环,其中R9R10由以下结构表示:-(CH2)n-,op如果R11为C1-C4烷基,则通常被O,S或NR14中断,其中n为3、4或5的整数; Z为O,S或NR 14,R 12和R 13各自独立地为氢,C 1 -C 4烷基或C 1 -C 4烷氧基,并且当合在一起时,R 12和R 13可以形成5或6元饱和或不饱和环,任选地被其间断O,S或NR14,并且任选地被1-3个C1-C4烷基或C1-C4烷氧基取代; R14为C1-C4烷基; -使卤化铵化合物与至少约一摩尔当量的式894的第二酚化合物反应-2000年8月31日,作为新颖的是式V的中间体。

著录项

  • 公开/公告号IL120371B

    专利类型

  • 公开/公告日2000-08-31

    原文格式PDF

  • 申请/专利权人 WYETH HOLDINGS CORPORATION;

    申请/专利号IL120371

  • 发明设计人

    申请日1997-03-04

  • 分类号C07D239/52;C07D401/04;C07D403/04;C07D413/04;C07D417/04;

  • 国家 IL

  • 入库时间 2022-08-22 01:56:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号